Back

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

16 April 2021 (15:37 - 15:45)
Organised by:
Congress Presentation Part of: Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC) Risk Factors and Prevention EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

7 More presentations in this session

Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction
Mr G. Neif Vieira Musse (Sao Paulo, BR)
Video
Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary
Professor M. Minicucci (Botucatu, BR)
Video
Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.
Professor U. Landmesser (Berlin, DE)
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

Access the full session

Session thumbnail
Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)
Video

The Event

Event poster

ESC Preventive Cardiology 2021

16 April 2021 15:37 CET
You may be interested in
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Session
From risk factor management to treatment optimisation in patients with cardiac disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources